RXSTRxSight, Inc.vs its industry peers
A metric-by-metric comparison of RxSight, Inc. against Ophthalmic Goods — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RXSTThis | $260M#6 | — | 1.0x#4 | 1.9x#5 | -3.9%#7 | -41.5%#7 | -35.8%#6 | -0.0%#5 | — | 2#3 | -19.2%#7 | — |
| COO | $14.5B#2 | 62.9x#3 | 1.8x#5 | 3.5x#6 | 5.1%#6 | -4.4%#5 | 16.7%#2 | 4.6%#2 | 4.3%#2 | 6#2 | 4.8%#4 | — |
| BLCO | $6.0B#3 | — | 0.9x#3 | 1.2x#3 | 6.5%#5 | -13.6%#6 | 2.2%#4 | -5.6%#6 | 1.0%#4 | — | 24.1%#2 | — |
| EYE | $1.8B#4 | 39.3x#2 | 2.0x#6 | 0.9x#2 | — | — | 3.0%#3 | 3.3%#3 | 3.9%#3 | — | -7.4%#5 | — |
| STAA | $1.2B#5 | — | 3.4x#7 | 5.0x#8 | — | — | -38.3%#7 | -22.8%#7 | — | — | 36.9%#1 | — |
| LUCY | $4M#7 | — | 0.5x#2 | 1.6x#4 | 62.6%#1 | 2.3%#3 | -285.1%#8 | -90.7%#8 | — | — | -64.7%#9 | — |
| LUCYW | $320186#8 | — | 0.0x#1 | 0.1x#1 | 62.6%#1 | 2.3%#3 | -285.1%#8 | -90.7%#8 | — | — | -54.5%#8 | — |
| ALC | $34.2B#1 | 9.7x#1 | 4.7x#8 | 4.8x#7 | 10.5%#4 | 10.1%#2 | 34.5%#1 | 30.5%#1 | 42.7%#1 | 7#1 | -17.7%#6 | 3.0%#1 |
| WRBY | — | 2824.5x#4 | — | — | 13.0%#3 | 108.0%#1 | -0.6%#5 | 0.4%#4 | — | — | 19.6%#3 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3851). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice